close
Enquiry IconContact Us
Logo

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Dental membranes and bone graft substitutes are used for dental bone regeneration procedures in patients affected by oral health disorders such as periodontal diseases and oral cancer. Dental membranes are used alongside dental bone grafts to allow cell proliferation. Major factors contributing to growth of the dental membrane and bone graft substitutes market are growing number of oral health issues, increasing product launches, and rising dental health expenditure. For instance, in April 2018, Geistlich Pharma North America Inc. announced the launch of two new resorbable collagen membranes Geistlich Bio-Gide Compressed and Geistlich Bio-Gide Shape.

The U.S. dental membrane and bone graft substitutes market is estimated to be valued at US$ 171.9 million in 2021 and is expected to exhibit a CAGR of 9.9% during the forecast period (2021-2028).

Figure 1. U.S. Dental Membrane and Bone Graft Substitutes Market Share in Terms of Value (US$ Mn), By Product Type, 2021

U.S. Dental Membrane and Bone Graft Substitutes  | Coherent Market Insights

Increasing oral health diseases is expected to drive the market growth over the forecast period.

Increasing oral health diseases such as cavities and gum disease is the leading factor for growth of dental membrane and bone graft substitutes market across the globe. The factors leading to oral health issue includes unhealthy diet, tobacco use, excess alcohol consumption, and poor oral hygiene. For instance, according to the Centers for Disease Control and Prevention report 2019-2020, in the U.S., more than a quarter (26%) of adults had untreated tooth decay and almost half (46%) of all adults 30 years and older had signs of gum disease.

request-sample

U.S. Dental Membrane and Bone Graft Substitutes Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 171.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 9.9% 2028 Value Projection: US$ 333.6 Mn
Geographies covered:
  • North America: U.S.
Segments covered:
  • By Product Type: Dental Membrane (Resorbable Membranes, Non-resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Synthetic Bone Graft Substitute)
  • By Material: Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, Others
  • By Application: Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), Guided Tissue Regeneration (GTR)
  • By End User: Hospitals, Dental Clinics, Others
Companies covered (8):

Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd.

Growth Drivers:
  • Disease outbreaks such as coronavirus disease (COVID 19)
  • High prevalence of malaria and rheumatoid arthritis
  • Increasing product launches and approvals
Restraints & Challenges:
  • Lack of evidences associated with the treatment coronavirus disease (COVID 19)

Figure 2. U.S. Dental Membrane and Bone Graft Substitutes Market Share (%), By Application, 2021

U.S. Dental Membrane and Bone Graft Substitutes  | Coherent Market Insights

Increasing product launches is expected to drive the market growth during the forecast period.

Increasing demand for efficient implants and membrane for dental restoration due to increasing oral health issues is expected to propel growth of the U.S. dental membrane and bone graft substitute market during the forecast period. In order to cater to increasing demand, manufacturers are focusing on developing new and highly efficient products included in implants and restoration. For instance, in February 2019, Zimmer Biomet Holdings, a global healthcare company, announced the expansion of its dental product portfolio to include non-resorbable membranes and sutures. The new OsseoGuard non-resorbable product line includes dense PTFE (polytetrafluoroethylene) membranes in multiple texture variations as well as titanium mesh and PTFE sutures. OsseoGuard products are currently available in the U.S. and Canada.

U.S. Dental Membrane and Bone Graft Substitutes Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper growth of the U.S. dental membrane and bone graft substitutes market during the forecast period. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 43 million cases and 0.69 million deaths due to coronavirus (COVID-19) were reported up till September 23, 2021, across the U.S.

Furthermore, the decrease in patients visiting dental clinics is a major challenge faced during the pandemic. For instance, according to the report published by the American Dental Association (ADA), April 2020, the COVID-19 pandemic had a significant impact on the dental care industry in the U.S. Over three-fourths of dental practices in the U.S. saw only emergency patients, and another 18% were completely closed. Moreover, according to the same source, the vast majority of dentists reported that their total collection volume was less than 5% of what is typical. Moreover, according to ADA's analysis, there was a 66% reduction in the U.S. dental spending in 2020 compared to pre-pandemic projections, which could lead to 32% reduction of dental spending in 2021.

U.S. Dental Membrane and Bone Graft Substitutes Market: Restraint

The high cost of dental membranes and bone grafts is expected to impede the U.S. dental membranes and bone graft substitutes market growth over the forecast period. The cost of a bone graft can vary substantially depending on the case and the condition of the patient’s jawbone. The typical costs associated with simple bone grafting for dental purposes using synthetic bone can cost between US$ 300 and US$ 800 for a single implant area.

Key Players

Major players operating in the U.S. dental membrane and bone graft substitutes market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.

Bone grafting is a procedure used in dentistry to increase the density and volume of natural jawbone tissue. Natural bone grows and eventually completely replaces the graft material. Natural bone grafts such as allografts consists of demineralized bone matrix, which has better osteoconductive and osteoinductive activity. Moreover, synthetic bone grafts include grafts made of ceramic, composite, polymer, and bone morphogenetic proteins (BMPs). Furthermore, another essential product is dental membrane, which is often used for treatment of periodontal diseases and other oral health issues.

Market Dynamics

Key players in the market are focused on adopting strategies such as partnerships and acquisitions to expand their product portfolio and geographical positioning in the U.S. dental membranes and bone graft substitutes market. For instance, in June 2020, Geistlich Biomaterials announced expansion of their portfolio of regenerative and complimentary products through a new distribution partnership with Osteogenics Biomedical in the U.S. Furthermore, in September 2021, Straumann Group, a global provider of denture and orthodontic solutions, announced the establishment of a strategic partnership with Aspen Dental Management, Inc. (ADMI) to provide dental implant solutions to more than 1,000 ADMI affiliated offices across the U.S.

Key features of the study:

  • This report provides an in-depth analysis of the U.S. dental membrane and bone graft substitutes market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. dental membrane and bone graft substitutes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. dental membrane and bone graft substitutes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the U.S. dental membrane and bone graft substitutes market

Detailed Segmentation:

  • U.S. Dental Membrane and Bone Graft Substitutes Market, By Product Type:
    • Dental Membrane
      • Resorbable Membranes
      • Non-resorbable Membranes
    • Bone Graft Substitutes
      • Demineralized Bone Matrix (DBM)
      • Allograft
      • Xenograft
      • Synthetic Bone Graft Substitute
  • U.S. Dental Membrane and Bone Graft Substitutes Market, By Material:
    • Collagen
    • Hydrogel
    • Hydroxyapatite (HA)
    • Tricalcium Phosphate (TCP)
    • Polytetrafluoroethylene
    • Human Cells Source
    • Others
  • U.S. Dental Membrane and Bone Graft Substitutes Market, By Application:
    • Socket Preservation
    • Ridge Augmentation
    • Sinus Lifts
    • Guided Bone Regeneration (GBR)
    • Guided Tissue Regeneration (GTR)
  • U.S. Dental Membrane and Bone Graft Substitutes Market, By End User:
    • Hospitals
    • Dental Clinics
    • Others
  • Company Profiles
    • Institut Straumann AG*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Nobel Biocare Services AG
    • Geistlich Pharma AG
    • Zimmer Biomet Holdings, Inc.
    • Dentsply Sirona, Inc.
    • BioHorizons, Inc.
    • NovaBone Products, LLC,
    • Collagen Matrix, Inc.
    • Maxigen Biotech, Inc.
    • Unicare Biomedical, Inc.
    • Collagen Matrix, Inc.
    • Osteogenics Biomedical
    • Medtronic
    • OUSIA

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Material
      • Market Snapshot, By Application
      • Market Snapshot, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Impact Analysis
    • Key Developments
    • Industry Trends
    • Extraction of Tooth and Bone Grafting Technique
    • Tooth Socket Preservation
    • Regulatory Scenario
    • Recent Product Approval/Launches
    • PEST Analysis
    • Porter’s Analysis
  4. U.S. Dental Membrane and Bone Graft Substitutes Market– Impact of Coronavirus (COVID-19) Pandemic
    • Impact on Demand
    • Impact on Dental Procedures
    • Impact on Healthcare
    • Epidemiology
  5. U.S. Dental Membrane and Bone Graft Substitutes Market, By Product Type, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Dental Membrane
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Resorbable Membranes
        • Non-resorbable Membranes
    • Bone Graft Substitutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Demineralized Bone Matrix (DBM)
        • Allograft
        • Xenograft
        • Synthetic Bone Graft Substitute
  6. U.S. Dental Membrane and Bone Graft Substitutes Market, By Material, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Collagen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Hydrogel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Hydroxyapatite (HA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Tricalcium Phosphate (TCP)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Polytetrafluoroethylene
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Human Cells Source
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  7. U.S. Dental Membrane and Bone Graft Substitutes Market, By Application, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Socket Preservation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ridge Augmentation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Sinus Lifts
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Guided Bone Regeneration (GBR)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Guided Tissue Regeneration (GTR)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  8. U.S. Dental Membrane and Bone Graft Substitutes Market, By End User, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Dental Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Institut Straumann AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Nobel Biocare Services AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Geistlich Pharma AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zimmer Biomet Holdings, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Dentsply Sirona, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • BioHorizons, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • NovaBone Products, LLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Collagen Matrix, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Maxigen Biotech, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Osteogenics Biomedical
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Medtronic
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • OUSIA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  10. Section
    • Research Methodology
    • About us

*Browse 25 market data tables and 30 figures on "U.S. Dental Membrane and Bone Graft Substitutes Market” - forecast to 2028

FAQgrowicon

Frequently Asked Questions

The U.S. dental membrane and bone graft substitutes market is estimated to be valued at US$ 171.9 million in 2021 and is expected to exhibit a CAGR of 9.9% between 2021 and 2028.
Factors such as increased spending on dental health and growing number of oral health issues are expected to drive the market growth during the forecast period.
Bone graft substitutes product type segment is expected to hold a major market share during the forecast period in the market.
The major factor hampering growth of the market include stringent government regulations and high cost of products and procedures.
Major players operating in the market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.